West Virginia Department of Health and Human Resources
Division of Tuberculosis Elimination
LATENT TUBERCULOSIS INFECTION RECORD
INITIAL REPORT ________ FINAL REPORT ___________
LAST NAME: _________________________FIRST NAME: ______________________MI:_____ Birth Date: ____/____/_______ Age: ___________
PHONE: (___) ____________ ADDRESS: ____________________________CITY:_________________COUNTY:___________STATE:____ ZIP: ______
SEX
RACE
ETHNICITY
REASON FOR TESTING
RESIDENCE
COUNTRY OF BIRTH
____WHITE
SCREENING FOR:
___PRIVATE RESIDENCE
____HISPANIC
___USA
___LOW RISK ___HIGH RISK
___HOMELESS
____ASIAN OR PACIFIC ISLANDER
________MALE
____NON‐HISPANIC
___OTHER (SPECIFY)
___WORK REQUIREMENT
___SHELTER
____BLACK
___SYMPTOMS/DIAGNOSTIC
___JAIL/PRISON
____UNKNOWN
__________________
____AMERCIAN INDIAN
___CONTACT TO TB CASE
___NURSING HOME
________FEMALE
IF OTHER, DATE OF ENTRY TO US:
____OTHER____________
___MIGRANT WORKER
___TREATMENT CENTER
______/______/_____________
___IMMIGRANT/REFUGEE
___OTHER_________________
DIABETES
CHEMICAL USE
HIV STATUS
LUNG
GI/GU
CANCER/CHEMO
HEPATITIS
MEDICATIONS
DISEASE
____NONE KNOWN
____NONE KNOWN
____UNKNOWN
____NONE KNOWN
____NONE KNOWN
____NONE KNOWN
____NONE KNOWN
____NONE KNOWN
____
INJECTED DRUG ABUSE
____DIET ONLY
____NEGATIVE
____ASTHMA
____GASTRECTOMY
____LEUKEMIA
____HEP A
____STEROIDS
____OTHER DRUG ABUSE
____ORAL MEDICINES
____POSITIVE
____SILICOSIS
____WT.LOSS SURGERY
____LYMPHOMA
____HEP B
____TNF INHIBITORS
____INSULIN
DATE:_________
____PNEUMONIA
____RENAL DISEASE
____OTHER MALIGNANCY
____HEP C
____ANTICONVULSANT
____EXCESS ALCOHOL
____UNCONTROLLED
TEST OFFERED:
____OTHER
____CIRRHOSIS
____IMMUNOSUPPESSIVE TX
____UNKNOWN TYPE
____TRANQUILIZER
____>2 DRINKS/DAY
____BINGE DRINKING
____YES ____NO
_________________
____OTHER
____BIRTH CONTROL
____PREGNANCY
________________________
____ANTICOAGULANT
____CURRENT TOBACCO
IF NO, REASON
EDD:____/____/____
____OTHER_________
AMOUNT_____________
NOT OFFERED:
____POST PARTUM
____ALLERGIES
_______________
PRIOR TB THERAPY
SYMPTOMS
SKIN TEST RESULTS
IGRA RESULTS
CHEST X‐RAY
____NONE
____NONE
TST #1
#1 TYPE _______________
DATE:_____/_____/_____
____POST PREVENTIVE THERAPY (PT)
____PRODUCTIVE COUGH
DATE:____/____/____
DATE:____/____/______
____PARTIAL PT
____HEMOPTYSIS
READING________MM
____POSITIVE
____NORMAL
____UNDERGOING PT
____SHORT OF BREATH
____NEGATIVE
____WITHIN NORMAL LIMITS
____POST BCG, YEAR________
____WEIGHT LOSSS
TST #2
____INDETERMINATE
____ABNORMALITY LIMITED TO CALCIFIED GRANULOMA(S)
____NIGHT SWEATS
DATE;____/____/____
____MULTI‐DRUG TX FOR ACTIVE TB
____FEVER
READING________MM
#2 TYPE _______________
____ABNORMAL
YEAR____________
____MALAISE
DATE:____/____/______
____POSSIBLE PRIMARY TB
____CURRENT WT:_______
KNOWN POSITIVE REACTOR
____POSITIVE
____EVIDENCE OF OLD INACTIVE TB
____OTHER_____________
_______MM YEAR;_____
____NEGATIVE
____SUSPECT ACTIVE TB
____INDETERMINATE
LAST KNOWN NEGATIVE TEST
____OTHER
DATE____/____/____
SEND ALL ABNORMAL CXR’S TO WVDTBE
REASONS FOR
ANTI‐TB DRUGS
DURATION
PREVENTIVE THERAPY
STOPPED PREVENTIVE THERAPY
PREVENTIVE THERAPY
____CONTACT, RECENT
____ISONIAZID (INH)
____2 MONTHS
____COMPLETED THERAPY ____LOST
____REACTOR
____RIFAMPIN (RIF)
____12 WEEKS
START DATE:____/____/______
____REFUSED ____DIED
____CONVERTOR
____RIFIPENTINE (RPT)
____4 MONTHS
____ACTIVE TB ____NOT INFECTED
____OLD TB DISEASE
____OTHER
____6 MONTHS
____MOVED ____OTHER
____OTHER HIGH RISK
______________________
____9 MONTHS
____ADVERSE REACTION _________________
_________________
____OTHER
STOP DATE____/____/____
_____________
MONTHS ON THERAPY________
____NOT RECOMMENDED
____REFUSED
CONTACT INVESTIGATION/INDEX CASE
REPORTING INFORMATION
LAST NAME_________________________________________________
PERSON REPORTING
FIRST NAME________________________________________________
_______________________________________________________
DOB________/________/________
DATE TB DIAGNOSED________/________/________
FACILITY OR LOCAL HEALTH DEPARTMENT
_______________________________________________________
_____UNKNOWN INDEX CASE
DATE OF REPORT_______/_____/___________
COMMENTS: _____________________________________________________________________________________________________________
________________________________________________________________________________________________________________________
TB‐101 07/01/2014